Jonathan D Buckley

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi request reprint Pesticide exposures in children with non-Hodgkin lymphoma
    J D Buckley
    Department of Preventive Medicine, University of Southern California, Los Angeles, USA
    Cancer 89:2315-21. 2000
  2. pmc Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group
    Elai Davicioni
    Department of Pathology, Childrens Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA
    J Clin Oncol 28:1240-6. 2010
  3. pmc Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group
    Elai Davicioni
    Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Am J Pathol 174:550-64. 2009

Collaborators

  • Timothy J Triche
  • Elai Davicioni
  • William H Meyer
  • James R Anderson
  • Michael J Anderson
  • Stephen J Qualman
  • James C Lynch
  • Deborah E Schofield
  • Friedrich Graf Finckenstein
  • Poul H B Sorensen
  • Hiroyuki Shimada

Detail Information

Publications3

  1. ncbi request reprint Pesticide exposures in children with non-Hodgkin lymphoma
    J D Buckley
    Department of Preventive Medicine, University of Southern California, Los Angeles, USA
    Cancer 89:2315-21. 2000
    ..However, to the authors' knowledge, data regarding pesticide exposures in children diagnosed with NHL have been lacking...
  2. pmc Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group
    Elai Davicioni
    Department of Pathology, Childrens Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA
    J Clin Oncol 28:1240-6. 2010
    ..We investigated whether tumors from diagnostic biopsies of primary rhabdomyosarcoma (RMS) contain relevant prognostic information in the form of gene expression signatures that can be used to model and predict outcome of patients...
  3. pmc Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group
    Elai Davicioni
    Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Am J Pathol 174:550-64. 2009
    ..Adoption of these molecular criteria may offer a more clinically relevant diagnostic scheme, thus potentially improving patient management and therapeutic RMS outcomes...